A 24‐WEEK STUDY TO EVALUATE THE EFFECT OF RILAPLADIB ON COGNITION AND CSF MARKERS OF ALZHEIMER'S DISEASE. (1st July 2014) - Maher‐Edwards, Gareth; De'Ath, Jeni; Barnett, Carly; Lavrov, Arseniy; Lockhart, Andrew